Effect of a modified saquinavir/ritonavir dosing regimen with lower dose lead-in phase on QTc interval, pharmacokinetics, antiviral activity and safety in treatment-naïve HIV-1-infected patients. Boffito M, et al. Drugs R D. 2015 Mar;15(1):141-53. PMID: 25742730.